How has been the historical performance of Salona Cotspin?
Salona Cotspin's historical performance shows fluctuating financial metrics, with net sales peaking at 722.26 Cr in March 2024 before declining to 662.16 Cr in March 2025, while cash flow from operating activities improved significantly to 63.00 Cr in March 2025. Overall, the company faced challenges with declining profits and assets despite some operational improvements.
Answer:The historical performance of Salona Cotspin shows a fluctuating trend in key financial metrics over the years.Breakdown:
Salona Cotspin's net sales peaked at 722.26 Cr in March 2024 but declined to 662.16 Cr by March 2025, following a significant increase from 486.91 Cr in March 2023. The total operating income mirrored this trend, with a decrease from 722.26 Cr in March 2024 to 662.16 Cr in March 2025. The company's total expenditure, excluding depreciation, was 630.19 Cr in March 2025, down from 692.03 Cr in March 2024. Operating profit (PBDIT) decreased slightly from 30.48 Cr in March 2024 to 32.12 Cr in March 2025, while profit before tax fell from 8.40 Cr to 5.54 Cr in the same period. Consequently, profit after tax also declined from 6.13 Cr to 3.13 Cr. The company's total assets decreased from 363.55 Cr in March 2024 to 354.50 Cr in March 2025, with total liabilities also declining from 363.55 Cr to 354.50 Cr. Cash flow from operating activities improved significantly to 63.00 Cr in March 2025, contrasting with a negative cash flow of -11.00 Cr in March 2024. Overall, Salona Cotspin's financial performance reflects a mix of challenges and improvements across various metrics over the years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
